Chikashi Ishioka

Chikashi Ishioka

UNVERIFIED PROFILE

Are you Chikashi Ishioka?   Register this Author

Register author
Chikashi Ishioka

Chikashi Ishioka

Publications by authors named "Chikashi Ishioka"

Are you Chikashi Ishioka?   Register this Author

100Publications

1839Reads

14Profile Views

Importance of gastric cancer for the diagnosis and surveillance of Japanese Lynch syndrome patients.

J Hum Genet 2019 Dec 7;64(12):1187-1194. Epub 2019 Oct 7.

Division of Clinical Genome Research, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s10038-019-0674-5
Publisher Site
http://dx.doi.org/10.1038/s10038-019-0674-5DOI Listing
December 2019

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei.

Int J Clin Oncol 2019 Dec 10. Epub 2019 Dec 10.

Department of Medical Oncology, Tohoku University Hospital, Aoba-ku, Sendai, Miyagi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-019-01592-xDOI Listing
December 2019

Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model.

Cancer Immunol Immunother 2019 Nov 15;68(11):1769-1778. Epub 2019 Oct 15.

Department of Clinical Oncology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02413-wDOI Listing
November 2019

In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cells.

Cancer Med 2019 Sep 31;8(12):5662-5672. Epub 2019 Jul 31.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745845PMC
September 2019

BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number.

Mol Cancer Res 2018 10 1;16(10):1499-1511. Epub 2018 Jun 1.

Department of Cancer Biology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-18-0269DOI Listing
October 2018

Patient perceptions of curability and physician-reported disclosures of incurability in Japanese patients with unresectable/recurrent cancer: a cross-sectional survey.

Jpn J Clin Oncol 2018 Oct;48(10):913-919

Department of Nursing, Nagoya University Graduate School of Medicine and Department of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Miyagi.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyy112DOI Listing
October 2018

End-of-life care for cancer patients in Japanese acute care hospitals: A nationwide retrospective administrative database survey.

Jpn J Clin Oncol 2018 Oct;48(10):877-883

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyy117DOI Listing
October 2018

[Why Cardio-Oncology Is Necessary Today - From a Viewpoint of the Tumor Internal Medicine].

Authors:
Chikashi Ishioka

Gan To Kagaku Ryoho 2017 Dec;44(13):2048-2051

Dept. of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University.

View Article

Download full-text PDF

Source
December 2017

IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model.

Cancer Immunol Immunother 2017 Nov 21;66(11):1485-1496. Epub 2017 Jul 21.

Department of Clinical Oncology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2043-6DOI Listing
November 2017

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.

BMC Cancer 2017 Nov 7;17(1):723. Epub 2017 Nov 7.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3739-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678600PMC
November 2017

Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor.

Cancer Sci 2017 Jul 19;108(7):1469-1475. Epub 2017 May 19.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497724PMC
July 2017

Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines.

Oncol Rep 2017 Jul 30;38(1):31-42. Epub 2017 May 30.

Department of Clinical Oncology, IDAC, Tohoku University, Aoba-ku, Sendai 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2017.5684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492844PMC
July 2017

OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer.

Breast Cancer 2017 Mar 6;24(2):336-340. Epub 2016 Jun 6.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-016-0709-0DOI Listing
March 2017

IL4 from T Follicular Helper Cells Downregulates Antitumor Immunity.

Cancer Immunol Res 2017 01 5;5(1):61-71. Epub 2016 Dec 5.

Department of Clinical Oncology, Tohoku University Hospital, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-16-0113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385600PMC
January 2017

Current situation regarding central venous port implantation procedures and complications: a questionnaire-based survey of 11,693 implantations in Japan.

Int J Clin Oncol 2016 Dec 21;21(6):1172-1182. Epub 2016 Jun 21.

Department of Medical Oncology, Tohoku University Hospital, Tohoku University, Seiryo-machi 1-1, Aoba-ku, Sendai, 980-8574, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-016-1003-zDOI Listing
December 2016

CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.

Int J Clin Oncol 2016 Dec 19;21(6):1091-1101. Epub 2016 Jul 19.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1, Seiryo-machi, Aobaku, Sendai, 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-016-1017-6DOI Listing
December 2016

Reversibility of the thia-Michael reaction of cytotoxic C-curcuminoid and structure-activity relationship of bis-thiol-adducts thereof.

Org Biomol Chem 2016 Dec 1;14(45):10683-10687. Epub 2016 Nov 1.

Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aza-Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c6ob01771aDOI Listing
December 2016

Upper arm central venous port implantation: a 6-year single institutional retrospective analysis and pictorial essay of procedures for insertion.

PLoS One 2014 10;9(3):e91335. Epub 2014 Mar 10.

Department of Clinical Oncology, Tohoku University Hospital, Tohoku University, Aoba-ku, Sendai, Japan; Department of Clinical Oncology, Institute of Development, Aging, and Cancer, Tohoku University, Aoba-ku, Sendai, Japan.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0091335PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948863PMC
March 2016

Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer.

Int J Clin Oncol 2015 Dec 20;20(6):1147-55. Epub 2015 May 20.

Department of Clinical Oncology, Institute of Development, Aging and Cancer Tohoku University, 4-1 Seiryo-machi, Aobaku, Sendai, 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-015-0841-4DOI Listing
December 2015

Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma.

Cancer Sci 2015 Sep 10;106(9):1118-29. Epub 2015 Aug 10.

Department of Cancer Biology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582980PMC
September 2015

Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2.

Biochem Biophys Res Commun 2015 Aug 24;464(1):275-80. Epub 2015 Jun 24.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Seiryo-machi 4-1, Aoba-ku, Sendai 980-8575, Japan; Department of Medical Oncology, Tohoku University Hospital, Tohoku University, Seiryo-machi 1-1, Aoba-ku, Sendai 980-8574, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2015.06.142DOI Listing
August 2015

Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status: An Independent Prognostic Factor of Breast Cancer.

Am J Surg Pathol 2015 Aug;39(8):1026-34

*Division of surgical Oncology, Tohoku University School of Medicine ‡Department of Clinical Oncology, Research Institute of Development, Aging and Cancer, Tohoku University §Department of Pathology, Tohoku University Hospital, Sendai †Department of Breast Cancer Surgery, Ishinomaki Red Cross Hospital, Miyagi ∥Center for Kampo Medicine, Nerima General Hospital ¶Division of medical oncology, Juntendo University Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000386DOI Listing
August 2015

[Development of biomarkers for molecular target drugs].

Nihon Rinsho 2015 Aug;73(8):1308-12

View Article

Download full-text PDF

Source
August 2015

Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.

Sci Rep 2015 Aug 21;5:13249. Epub 2015 Aug 21.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Seiryo-machi 4-1, Aoba-ku, Sendai 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep13249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543981PMC
August 2015

Functional Complementation Assay for 47 MUTYH Variants in a MutY-Disrupted Escherichia coli Strain.

Hum Mutat 2015 Jul;36(7):704-11

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22794DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682456PMC
July 2015

[Present status and future prospect of the chemotherapy for ampullary cancer].

Nihon Rinsho 2015 Mar;73 Suppl 3:737-40

View Article

Download full-text PDF

Source
March 2015

Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.

Cancer Sci 2015 Feb 28;106(2):208-15. Epub 2015 Jan 28.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12585DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399029PMC
February 2015

[Points of management for elderly patients in chemotherapy].

Nihon Rinsho 2015 Feb;73 Suppl 2:51-6

View Article

Download full-text PDF

Source
February 2015

[Comprehensive geriatric assessment for elderly patients with cancer].

Nihon Rinsho 2015 Feb;73 Suppl 2:701-5

View Article

Download full-text PDF

Source
February 2015

Transgenic expression of the N525S-tuberin variant in Tsc2 mutant (Eker) rats causes dominant embryonic lethality.

Sci Rep 2014 Aug 4;4:5927. Epub 2014 Aug 4.

Department of Pathology and Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep05927DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379989PMC
August 2014

High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H.

Oncol Rep 2014 Mar 30;31(3):1043-50. Epub 2013 Dec 30.

Department of Clinical Oncology, IDAC, Tohoku University, Sendai, Miyagi 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2013.2953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926671PMC
March 2014

The BRCA1/BARD1-interacting protein OLA1 functions in centrosome regulation.

Mol Cell 2014 Jan 27;53(1):101-14. Epub 2013 Nov 27.

Department of Molecular Immunology, Institute of Development, Aging, and Cancer (IDAC), Tohoku University, 4-1 Seiryomachi Aoba-ku, Sendai 980-8575, Japan. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10972765130079
Publisher Site
http://dx.doi.org/10.1016/j.molcel.2013.10.028DOI Listing
January 2014

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer.

Int J Clin Oncol 2013 Aug 26;18(4):670-7. Epub 2012 May 26.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aobaku, Sendai, 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-012-0422-8DOI Listing
August 2013

[Brief description of the revised plan to promote cancer control programs in Miyagi].

Authors:
Chikashi Ishioka

Gan To Kagaku Ryoho 2013 May;40(5):570-4

Dept. of Clinical Oncology, Tohoku University, Japan.

View Article

Download full-text PDF

Source
May 2013

Recent advances in diagnosis and treatment for malignancies of the gastrointestinal tract.

Digestion 2012 19;85(2):95-8. Epub 2012 Jan 19.

Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000334677DOI Listing
March 2013

Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing.

Hum Mutat 2013 Mar 12;34(3):439-45. Epub 2012 Dec 12.

Department of Biomedical Informatics and the Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906639PMC
March 2013

Practical utility of circulating tumour cells as biomarkers in cancer chemotherapy for advanced colorectal cancer.

Anticancer Res 2013 Feb;33(2):625-9

Department of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.

View Article

Download full-text PDF

Source
February 2013

Overexpression of DRAM enhances p53-dependent apoptosis.

Cancer Med 2013 Feb 3;2(1):1-10. Epub 2013 Feb 3.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University , 4-1 Seiryo-machi, Aoba-ku, Sendai, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cam4.39
Publisher Site
http://dx.doi.org/10.1002/cam4.39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797565PMC
February 2013

Suppression of FUT1 attenuates cell proliferation in the HER2-overexpressing cancer cell line NCI-N87.

Oncol Rep 2013 Jan 1;29(1):13-20. Epub 2012 Nov 1.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2012.2120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583482PMC
January 2013

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis.

Nucleic Acids Res 2013 Jan 17;41(Database issue):D962-9. Epub 2012 Nov 17.

Université Pierre et Marie Curie-Paris6, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gks1033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531172PMC
January 2013

IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas.

Int J Clin Oncol 2012 Dec 6;17(6):551-61. Epub 2011 Oct 6.

Department of Neurosurgery, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-011-0323-2DOI Listing
December 2012

Aberrant splicing caused by a MLH1 splice donor site mutation found in a young Japanese patient with Lynch syndrome.

Fam Cancer 2012 Dec;11(4):559-64

Department of Clinical Oncology, Institute of Development, Aging and Cancer, and Tohoku University Hospital, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10689-012-9547-1
Publisher Site
http://dx.doi.org/10.1007/s10689-012-9547-1DOI Listing
December 2012

Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors.

Cancer Sci 2012 Nov 12;103(11):1994-2001. Epub 2012 Oct 12.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12002DOI Listing
November 2012

[C-kit and other receptor tyrosine kinases play a crucial role in oncogenic signaling and drug-resistance].

Nihon Rinsho 2012 Nov;70 Suppl 8:36-40

Department of Clinical Oncology, Tohoku University Hospital.

View Article

Download full-text PDF

Source
November 2012

[Transition and perspective of chemotherapy in breast cancer].

Nihon Rinsho 2012 Sep;70 Suppl 7:23-8

Department of Clinical Oncology. Tohoku University Hospital.

View Article

Download full-text PDF

Source
September 2012

[Treatment of bone metastasis - focusing on drug treatment].

Authors:
Chikashi Ishioka

Gan To Kagaku Ryoho 2012 Aug;39(8):1169-73

Dept. of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Miyagi, Japan.

View Article

Download full-text PDF

Source
August 2012

Three cases of kindred with familial breast cancer in which carrier detection by BRCA gene testing was performed on family members.

Breast Cancer 2012 Jul 6;19(3):270-4. Epub 2009 Oct 6.

Department of Surgery, Breast Cancer Center, Familial Tumor Clinic, Hoshi General Hospital, 2-1-16 Omachi, Koriyama, 963-8501, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12282-009-0157-1
Publisher Site
http://dx.doi.org/10.1007/s12282-009-0157-1DOI Listing
July 2012

Induction of apoptosis by cytoplasmically localized wild-type p53 and the S121F mutant super p53.

Oncol Lett 2012 May 29;3(5):978-982. Epub 2012 Feb 29.

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi 980-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2012.624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389701PMC
May 2012

[Infusion reaction and anaphylaxis].

Gan To Kagaku Ryoho 2011 Nov;38(11):1753-7

Dept. of Clinical Oncology, Tohoku University Hospital, Japan.

View Article

Download full-text PDF

Source
November 2011

Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma.

Anticancer Res 2011 Nov;31(11):3719-26

Department of Clinical Oncology, Faculty of Medicine, Akita University, Hondo1-1-1, Akita, Japan.

View Article

Download full-text PDF

Source
November 2011

[Predictive biomarkers of anti-EGFR monoclonal anti-body in colorectal cancer].

Gan To Kagaku Ryoho 2011 Jul;38(7):1079-83

Institute of Development, Aging and Cancer, Tohoku University, Japan.

View Article

Download full-text PDF

Source
July 2011

Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.

Cancer Sci 2011 May 24;102(5):1045-51. Epub 2011 Feb 24.

Department of Clinical Oncology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2011.01886.xDOI Listing
May 2011

Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo.

BMC Pharmacol 2011 May 28;11. Epub 2011 May 28.

Dept. Clinical Oncology, Institute of Development, Aging, and Cancer, Tohoku University, Seiryo-cho 4-1, Aoba-ku, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2210-11-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115866PMC
May 2011

Contribution of autophagic cell death to p53-dependent cell death in human glioblastoma cell line SF126.

Cancer Sci 2011 Apr 11;102(4):799-807. Epub 2011 Feb 11.

Department of Clinical Oncology, Research Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2011.01857.xDOI Listing
April 2011

Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology.

Int J Clin Oncol 2010 Jun 24;15(3):227-33. Epub 2010 Mar 24.

Department of Clinical Research and Informatics, Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-010-0060-yDOI Listing
June 2010

[Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody].

Gan To Kagaku Ryoho 2010 May;37(5):795-8

Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai, Japan.

View Article

Download full-text PDF

Source
May 2010

Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.

Bioorg Med Chem 2010 Feb 23;18(3):1083-92. Epub 2009 Dec 23.

Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aobayama, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2009.12.045DOI Listing
February 2010

alphaB-crystallin: a novel p53-target gene required for p53-dependent apoptosis.

Cancer Sci 2009 Dec 18;100(12):2368-75. Epub 2009 Aug 18.

Department of Clinical Oncology, Research Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2009.01316.xDOI Listing
December 2009

[Status of components in EGFR-related signal transduction as predictive markers for anti-EGFR antibody therapy in colorectal cancer treatment].

Gan To Kagaku Ryoho 2009 Jul;36(7):1063-6

Institute of Development, Aging and Cancer, Tohoku University, Tohoku University Hospital, Aoba-ku, Sendai, Japan.

View Article

Download full-text PDF

Source
July 2009